Ex vivo confocal microscopy: revolution in fast pathology in dermatology

Confocal microscopy with in vivo and ex vivo modalities has been used in the evaluation of skin cancer and other dermatological disorders. Recent developments in ex vivo confocal microscopy allow for faster pathology assessment with greater accuracy by the visualization of cellular and architectural details, similarly to standard pathology, in either paraffin‐embedded or frozen samples. They include the possibility of multimodal confocal microscopy using different lasers and fusion images. New staining protocols including immunostaining, with no damage to conventional histopathology preparation, have been recently described in melanocytic tumours and inflammatory skin diseases. Digital staining with haematoxylin and eosin is also incorporated in the new devices. In this review the applications of ex vivo confocal microscopy will be presented with the description of the technique and the technology, clinical evidence in dermatology and other fields, and further applications.

Business Inquiries

SurgiVance™, Inc.
310 East 67th St.
Suite 2-91
New York, NY 10065
info@surgivance.com
+1-503-708-7078

Careers

SurgiVance™ is currently looking for engineers with expertise in opto-mechanics, deep-learning, or image recognition experience.

Please send your CV to info@surgivance.com.


SurgiVance is supported by the National Science Foundation and the National Institutes of Health

© 2022 SurgiVance™, Inc.
*SurgiVance™ has not yet been reviewed by the FDA and may not be used to manage patient care.